Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Operations (2016 - 2025)

Haemonetics has reported Cash from Operations over the past 17 years, most recently at 93564000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 93564000.0 for Q4 2025, up 113.78% from a year ago — trailing twelve months through Dec 2025 was 338837000.0 (up 162.16% YoY), and the annual figure for FY2025 was 181725000.0, changed 0.01%.
  • Cash from Operations for Q4 2025 was 93564000.0 at Haemonetics, down from 111321000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for HAE hit a ceiling of 116557000.0 in Q1 2025 and a floor of 27421000.0 in Q2 2024.
  • Median Cash from Operations over the past 5 years was 55628000.0 (2022), compared with a mean of 51631200.0.
  • Peak annual rise in Cash from Operations hit 8204.81% in 2024, while the deepest fall reached 243.67% in 2024.
  • Haemonetics' Cash from Operations stood at 43460000.0 in 2021, then surged by 48.22% to 64415000.0 in 2022, then plummeted by 100.84% to 540000.0 in 2023, then skyrocketed by 8204.81% to 43766000.0 in 2024, then skyrocketed by 113.78% to 93564000.0 in 2025.
  • The last three reported values for Cash from Operations were 93564000.0 (Q4 2025), 111321000.0 (Q3 2025), and 17395000.0 (Q2 2025) per Business Quant data.